NH
$16.02
-0.07
(-0.47%)
As of Oct 5, 2026, 3:41 PM EDT
Price history
National Healthcare Properties (NHP) is trading down at $16.02 (-0.47%), as of the latest quote. It is a Russell 2000 constituent in the Real Estate sector.
IPO: April 22, 2026 · $12.00 offering · NASDAQ · View IPO details →
National Healthcare Properties revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $302.6M | $311.2M | $362.4M | $374.9M | $381.6M | $329.4M | $335.8M | $345.9M | $353.8M | $342.3M |
| Growth (year over year) | +22.3% | +2.8% | +16.5% | +3.5% | +1.8% | −13.7% | +2.0% | +3.0% | +2.3% | −3.3% |
| Gross profit | $130.5M | $124.9M | $141.4M | $140.7M | $138.1M | $123.5M | $122.4M | $128.1M | $132.3M | $123.4M |
| Gross margin | 43.1% | 40.1% | 39.0% | 37.5% | 36.2% | 37.5% | 36.4% | 37.0% | 37.4% | 36.0% |
| Operating income | −$3.31M | −$12.2M | −$3.18M | −$31.8M | −$19.9M | −$37.4M | −$31.5M | −$4.74M | −$123.5M | $3.30M |
| Operating margin | −1.1% | −3.9% | −0.9% | −8.5% | −5.2% | −11.4% | −9.4% | −1.4% | −34.9% | 1.0% |
| Net income | −$20.9M | −$42.5M | −$52.8M | −$88.1M | −$78.8M | −$92.9M | −$93.3M | −$86.1M | −$203.5M | −$71.1M |
| Net margin | −6.9% | −13.7% | −14.6% | −23.5% | −20.6% | −28.2% | −27.8% | −24.9% | −57.5% | −20.8% |
| EPS (diluted) | −$3.84 | −$7.52 | −$8.96 | −$3.52 | −$2.96 | −$3.28 | −$3.30 | −$3.04 | −$7.19 | −$2.51 |
| Balance sheet | ||||||||||
| Cash and equivalents | $29.2M | $94.2M | $77.3M | $95.7M | $72.4M | $59.7M | $53.7M | $46.4M | $21.7M | $57.6M |
| Total assets | $2.19B | $2.37B | $2.38B | $2.33B | $2.29B | $2.21B | $2.18B | $2.15B | $1.95B | $1.71B |
| Total liabilities | $689.4M | $1.02B | $1.14B | $1.22B | $1.33B | $1.17B | $1.18B | $1.24B | $1.26B | $1.11B |
| Shareholders' equity | $1.50B | $1.35B | $1.23B | $1.10B | $957.0M | $1.03B | $992.6M | $894.2M | $684.6M | $600.1M |
| Cash flow | ||||||||||
| Operating cash flow | $78.7M | $64.0M | $54.2M | $47.4M | $41.8M | $38.9M | $28.3M | $21.6M | −$79.8M | $6.95M |
| Capital expenditure | $7.48M | $8.28M | $12.9M | $16.7M | — | — | — | — | — | — |
| Free cash flow | $71.2M | $55.7M | $41.2M | $30.7M | — | — | — | — | — | — |
| Dividends paid | $75.4M | $76.7M | $55.3M | $51.4M | $31.4M | $0 | $0 | — | — | — |
| Share buybacks | $12.2M | $33.6M | $14.2M | $21.1M | $10.5M | $0 | $0 | — | — | — |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $88.9M | $87.7M | $86.4M | $85.3M | $86.0M | $84.5M | $86.3M | $87.5M |
| Growth (year over year) | +3.8% | +1.1% | −2.1% | −3.9% | −3.3% | −3.7% | −0.2% | +2.6% |
| Gross profit | $32.5M | $32.8M | $28.6M | $31.2M | $32.2M | $31.5M | $33.4M | $33.4M |
| Gross margin | 36.6% | 37.4% | 33.1% | 36.5% | 37.4% | 37.2% | 38.7% | 38.2% |
| Operating income | −$20.9M | −$1.05M | $13.0M | −$5.52M | $2.38M | −$6.58M | $10.1M | $5.09M |
| Operating margin | −23.5% | −1.2% | 15.1% | −6.5% | 2.8% | −7.8% | 11.7% | 5.8% |
| Net income | −$44.1M | −$20.4M | −$5.02M | −$24.2M | −$15.9M | −$26.0M | −$7.60M | −$8.14M |
| Net margin | −49.6% | −23.3% | −5.8% | −28.3% | −18.5% | −30.8% | −8.8% | −9.3% |
| EPS (diluted) | −$1.56 | −$0.72 | −$0.18 | −$0.85 | −$0.56 | −$0.92 | −$0.27 | −$0.13 |
| Balance sheet | ||||||||
| Cash and equivalents | $32.9M | $21.7M | $71.4M | $47.1M | $47.1M | $57.6M | $52.8M | $245.7M |
| Total assets | $2.00B | $1.95B | $1.83B | $1.76B | $1.74B | $1.71B | $1.70B | $1.98B |
| Total liabilities | $1.29B | $1.26B | $1.15B | $1.11B | $1.11B | $1.11B | $1.10B | $919.0M |
| Shareholders' equity | $702.6M | $684.6M | $674.6M | $647.0M | $627.2M | $600.1M | $592.2M | $1.05B |
| Cash flow | ||||||||
| Operating cash flow | −$95.2M | $6.45M | −$21.2M | $8.05M | $10.2M | $9.96M | $9.01M | $21.6M |
From National Healthcare Properties's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About National Healthcare Properties
- Headquarters
- New York, New York From SEC filings, Oct 2026
Recent News (2)
-
National Healthcare Properties converts Class A shares to common stock
National Healthcare Properties converts Class A shares to common stock
-
National Healthcare Properties Announces Conversion of Class A Common Stock into Common Stock NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP) (the “Company”) announced today that, as previously disclosed, all outstanding shares of its Class A co…
Other Real Estate companies to compare with NHP
- MMI Marcus & Millichap Inc
- MPT Medical Properties Trust
- MRP Millrose Properties
- NHI National Health Investors REIT Inc
- NLOP Net Lease Office Properties
- NMRK Newmark Group Inc Class a
- NNN NNN REIT
- NTST Netstreit Corp